Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.580
0.00 (0.00%)
At close: Dec 20, 2024, 4:00 PM
1.620
+0.040 (2.53%)
After-hours: Dec 20, 2024, 5:40 PM EST

Cerus Revenue

Cerus had revenue of $46.02M in the quarter ending September 30, 2024, with 15.70% growth. This brings the company's revenue in the last twelve months to $176.23M, up 14.71% year-over-year. In the year 2023, Cerus had annual revenue of $156.37M, down -3.51%.

Revenue (ttm)
$176.23M
Revenue Growth
+14.71%
P/S Ratio
1.64
Revenue / Employee
$276,655
Employees
637
Market Cap
293.43M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023156.37M-5.68M-3.51%
Dec 31, 2022162.05M31.19M23.83%
Dec 31, 2021130.86M38.94M42.36%
Dec 31, 202091.92M17.27M23.14%
Dec 31, 201974.65M13.74M22.56%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Canopy Growth 207.63M
Rigel Pharmaceuticals 157.37M
Sage Therapeutics 106.40M
CVRx, Inc. 47.26M
Aclaris Therapeutics 27.08M
Silence Therapeutics 21.77M
XOMA Royalty 21.61M
Nyxoah 5.67M
Revenue Rankings